DonEEslinMD

Pediatric Hematology & Oncology • Tampa, FL

Physician

Join to view full profile

Dr. Eslin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Eslin's full profile

Already have an account?

Office
3001 W Dr Martin Luther King Jr Blvd
Tampa, FL 33607
Phone+1 813-321-6820

Fax+1 813-287-6306
Is this information wrong?

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Orlando Health/Arnold Palmer Hospital for ChildrenResidency, Pediatrics, 1997 - 2000
Marshall University Joan C. Edwards School of MedicineClass of 1997

Certifications & Licensure

FL State Medical License 2000 - 2025
PA State Medical License 2000 - 2004
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14
Completed
Phase 2
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Start of enrollment: 2010 Jun 01
Terminated
Phase 3
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
Completed
Phase 1
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Mar 04
Completed
Not Applicable
Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma Start of enrollment: 2014 Jun 06
Completed
Phase 1, Phase 2
Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08
Completed
Not Applicable
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy Start of enrollment: 2015 Sep 01
Recruiting
Phase 2
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Correction to: Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers.
Priya K Patel, Michell Lozano Chinga, Melis Yilmaz, Sonia Joychan, Boglarka Ujhazi, Maryssa Ellison, Sumai Gordon, Daime Nieves, Krisztian Csomos, Don Eslin, Zeinab A ...> ;Journal of Clinical Immunology. 2024 Feb 29
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Giselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, Jacqueline Kraveka, William Ferguson, Abhinav B Nagulapally, Karl Dykema, Valerie I Brown, Michael...> ;Genome Medicine. 2024 Feb 12
Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers.
Patel, P., Chinga, M., Yilmaz, M., Joychan, S., Ujhazi, B., Ellison, M., Gordon, S., Nieves, D., Csomos, K., Eslin, D., Afify, Z., Meznarich, J., Bohnsack, J., Walkovi...> ;Journal of Clinical Immunology. 2024 Jan 17
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Don Eslin, Peter E Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts, Jacqueline Kraveka, Deanna Mitchell, Michael S Isakoff, Jawhar Rawwas, Randal K Wada, ...> ;International Journal of Cancer. 2023 Sep 1
8 citations
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
Sara A. Byron, William P.D. Hendricks, Abhinav Nagulapally, Jacqueline M. Kraveka, William S. Ferguson, Valerie I. Brown, Don E Eslin, Deanna Mitchell, Albert Corneliu...> ;Cancer Research. 2021 Oct 5
31 citations
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C. Lewis, Jacqueline M. Kraveka, William S. Ferguson, Don Eslin, Valerie I. Brown, Genevieve Bergendahl, William Roberts, Randal K. Wada, Javier Oesterheld, ...> ;International Journal of Cancer. 2020 Dec 1
3 citations
Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells
Shruti Patil, Umesh T. Sankpal, Myrna Hurtado, W. Paul Bowman, Jeffrey Murray, Kathleen Borgmann, Anuja Ghorpade, Robert M. Sutphin, Don Eslin, Riyaz Basha> ;Gene. 2019 Jul 15
2 citations
Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells
Sagar Shelake, Umesh T. Sankpal, Don Eslin, W. Paul Bowman, Jerry W. Simecka, Sangram Raut, Anish Ray, Riyaz Basha> ;Apoptosis. 2019 Feb 1
58 citations
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen A. Neville, Don Eslin, Valerie I. Brown, William Roberts, Randal K. Wada...> ;Scientific Reports. 2018 Sep 27
4 citations
Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
Sagar Shelake, Don Eslin, Robert M. Sutphin, Umesh T Sankpal PhD, Anmol Wadwani, Laura E. Kenyon, Leslie Tabor-Simecka, W. Paul Bowman, Jamboor K. Vishwanatha, Riyaz B...> ;International Journal of Developmental Neuroscience. 2015 Nov 1
18 citations
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
Deanna Mitchell, Genevieve Bergendahl, William S. Ferguson, William Roberts, Timothy Higgins, Takamaru Ashikaga, M.J. DeSarno, Joel Kaplan, Jacqueline M. Kraveka, Don ...> ;Pediatric Blood & Cancer. 2016 Jan 1
19 citations
Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
Giselle Saulnier Sholler, Jeffrey P. Bond, Genevieve Bergendahl, Akshita Dutta, Julie A. Dragon, Kathleen A. Neville, William S. Ferguson, William Roberts, Don Eslin, ...> ;Cancer Medicine. 2015 Jun 1
100 citations
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Giselle Saulnier Sholler, Eugene W. Gerner, Genevieve Bergendahl, Robert B. MacArthur, Alyssa VanderWerff, Takamaru Ashikaga, Jeffrey P. Bond, William S. Ferguson, Wil...> ;Plos One. 2015 May 27
6 citations
Anti-leukemic response of a NSAID, tolfenamic acid.
Robert M. Sutphin, Sarah F. Connelly, Chris M. Lee, Umesh T. Sankpal, Don Eslin, Moeez Khan, Hima Pius, Riyaz Basha> ;Targeted Oncology. 2014 Jun 1
17 citations
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study
Don Eslin, Chris M. Lee, Umesh T. Sankpal, Pius Maliakal, Robert M. Sutphin, Liz Abraham, Riyaz Basha> ;Tumour Biology. 2013 May 18
22 citations
Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma
Don Eslin, Umesh T. Sankpal, Chris M. Lee, Robert M. Sutphin, Pius Maliakal, Erika Currier, Giselle L. Sholler, Moeez Khan, Riyaz Basha> ;Molecular Carcinogenesis. 2013 May 1
17 citations
Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation
Umesh T. Sankpal, Chris M. Lee, Sarah F. Connelly, Omer Kayaleh, Don Eslin, Robert M. Sutphin, Steven Goodison, Lina Adwan, Nasser H. Zawia, Lenard M. Lichtenberger, R...> ;Cellular Physiology and Biochemistry. 2013 Jan 1
6 citations
A rare case of malignant pediatric ectomesenchymoma arising from the falx cerebri.
Dana L. Altenburger, Aaron S. Wagner, Don Eslin, Gary S. Pearl, Jogi V. Pattisapu> ;Journal of Neurosurgery. Pediatrics. 2011 Jan 1
49 citations
Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
Colin Moore, Don Eslin, Alejandro G. Levy, Jessica Roberson, Vincent Giusti, Robert M. Sutphin> ;Pediatric Blood & Cancer. 2010 Dec 1
101 citations
The relative role of PLCβ and PI3Kγ in platelet activation
Lurong Lian, Yanfeng Wang, Julia Draznin, Don E. Eslin, Joel S. Bennett, Mortimer Poncz, Dianqing Wu, Charles S. Abrams> ;Blood. 2005 Jul 1
118 citations
Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin.
Don E. Eslin, Chunyan Zhang, Kathleen J. Samuels, Lubica Rauova, Li Zhai, Stefan Niewiarowski, Douglas B. Cines, Mortimer Poncz, M. Anna Kowalska> ;Blood. 2004 Nov 15
115 citations
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment
Helen Yarovoi, Dubravka Kufrin, Don E. Eslin, Michael A. Thornton, Sandra L. Haberichter, Qizhen Shi, Hua Zhu, Rodney M. Camire, Steve Fakharzadeh, M. Anna Kowalska, D...> ;Blood. 2003 Dec 1
51 citations
ANTITHROMBOTIC THROMBOCYTES: ECTOPIC EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN PLATELETS
Dubravka Kufrin, Don E. Eslin, Khalil Bdeir, Juan-Carlos Murciano, Alice Kuo, M. Anna Kowalska, Jay L. Degen, Bruce S. Sachais, Douglas B. Cines, Mortimer Poncz> ;Blood. 2003 Aug 1
4 citations
Nerve growth factor increases stimulus-evoked metabolic activity in acetylcholine-depleted barrel cortex.
Omid B Rahimi, Don E. Eslin, Glenwood F. Hill, Sharon L. Juliano> ;Somatosensory & Motor Research. 1999 Jan 1
10 citations
Developmental regulation of plasticity in cat somatosensory cortex
Sharon L. Juliano, Don E. Eslin, M. Tommerdahl> ;Journal of Neurophysiology. 1994 Oct 1
Join now to see all